About The Report
The touch activated phlebotomy devices market is expected to grow from USD 288.7 million in 2026 to USD 819.7 million by 2036, reflecting a compound annual growth rate (CAGR) of 11%. These devices are designed to simplify the process of blood collection by automating the venipuncture process, reducing the risk of needlestick injuries, and improving the efficiency and safety of phlebotomy procedures. The market’s growth is driven by the increasing adoption of automated and safer blood collection technologies, as well as the rising awareness of healthcare worker safety and patient comfort during procedures.
The demand for touch-activated phlebotomy devices is also fueled by the ongoing focus on improving healthcare practices and reducing complications associated with manual blood collection. The growing prevalence of chronic diseases, which require regular blood tests, and the rising number of outpatient procedures are expected to further support market expansion. Technological advancements that improve the precision and ease of blood collection procedures are also contributing to the market's growth.
The 10-year growth comparison for the touch-activated phlebotomy devices market shows a consistent and steady increase over the forecast period. Starting at USD 288.7 million in 2026, the market grows to USD 320.9 million in 2027 and USD 356.3 million in 2028, reflecting gradual adoption and increasing recognition of the benefits of touch-activated phlebotomy devices in reducing manual errors and improving safety.
From 2028 to 2030, the market continues to expand steadily, reaching USD 395.8 million in 2029 and USD 439.6 million in 2030. As the technology becomes more widely used in clinical and outpatient settings, the adoption accelerates. From 2030 to 2035, the market sees faster growth, reaching USD 488.1 million in 2031, USD 541.5 million in 2032, and USD 600.5 million in 2033, driven by the rising demand for safer, more efficient blood collection solutions.
By 2035, the market is projected to reach USD 738 million, with the final market value of USD 819.7 million expected by 2036. The comparison highlights steady growth, with a notable acceleration towards the latter part of the forecast period as healthcare systems increasingly adopt these devices for blood collection, improving both the safety and efficiency of procedures across hospitals and clinics globally.
| Metric | Value |
|---|---|
| Industry Sales Value (2026) | USD 288.7 million |
| Industry Forecast Value (2036) | USD 819.7 million |
| Industry Forecast CAGR (2026-2036) | 11% |
The global demand for touch activated phlebotomy devices is being driven by the need to improve safety, efficiency, and patient experience in blood collection procedures. Traditional venipuncture carries risks such as needlestick injuries for healthcare workers and discomfort for patients, especially those with difficult veins or in paediatric and geriatric populations. Touch activated phlebotomy devices incorporate mechanisms that stabilise the needle and collection assembly when contact with the skin is made, which enhances control during insertion and reduces unintended needle movement. This can lower the risk of needlestick injury, reduce sample haemolysis, and improve first-stick success rates, making these devices attractive to hospitals, diagnostic centres, and outpatient laboratories. Growing emphasis on healthcare worker safety, reinforced by occupational safety guidelines and campaigns, has increased adoption of engineered safety devices. In addition, expansion of routine diagnostic testing due to chronic disease monitoring, preventive health screening, and broader access to laboratory services supports increased utilization of advanced blood collection tools.
Future demand for touch activated phlebotomy devices is expected to grow as healthcare systems continue prioritising safety, quality, and operational efficiency. Advances in device ergonomics, user feedback features, and compatibility with existing blood collection systems will make these solutions more appealing to clinical teams. Integration with training programmes for nurses and phlebotomists can further improve adoption by reducing procedural variability and enhancing confidence in blood draws. As point-of-care testing and decentralized healthcare services expand, the ability to perform reliable blood draws outside the traditional lab setting will create additional demand for user-friendly, safety-enhancing devices. Regulatory environments that incentivise adoption of safer medical devices and reimbursement models that recognise the value of reducing workplace injuries and repeat procedures will also influence how widely these devices are deployed. Consumer expectations for less painful and safer blood collection, particularly in preventive health and chronic disease contexts, may further accelerate market growth. The emphasis on reducing occupational hazards, improving patient comfort, and streamlining clinical workflows is expected to sustain steady global expansion of the touch activated phlebotomy devices market.
The touch activated phlebotomy devices market is influenced by two primary segments: device types and use settings. Among the device types, touch-activated safety needles lead the market, accounting for 46% of the share, followed by touch-activated blood collection sets and touch-activated lancets. These devices are designed to improve the safety and efficiency of blood collection procedures. The market is also shaped by use settings such as hospitals, diagnostics/reference labs, clinics, and physician offices, with hospitals representing the largest share at 44%. The demand for touch activated phlebotomy devices is driven by the growing emphasis on patient and healthcare worker safety, as well as the need for more efficient, minimally invasive procedures. Regional factors, particularly in North America and Europe, play a significant role in the adoption of these devices. As healthcare facilities seek safer alternatives to traditional blood collection methods, the market for touch activated devices is expected to expand further.
Touch-activated safety needles represent the leading device type in the touch activated phlebotomy devices market, comprising 46% of the market share. The growing demand for these needles is largely driven by their ability to reduce the risk of needlestick injuries, which are a significant concern for healthcare workers. Touch-activated safety needles feature a mechanism that automatically shields the needle after use, minimizing the risk of accidental pricks. As hospitals and clinics continue to prioritize healthcare worker safety, the adoption of safety needles is rising.
In addition, touch-activated safety needles are designed to be user-friendly, enabling faster and more efficient blood collection, which is crucial in high-volume healthcare settings. The shift toward minimizing occupational health risks and improving the safety of phlebotomy procedures is a key driver behind the growth of this segment. Furthermore, regulatory standards in many regions, such as OSHA in the United States, mandate the use of safety-engineered devices, further boosting the demand for touch-activated safety needles. With their ability to enhance both safety and efficiency, touch-activated safety needles are expected to maintain their dominant position in the market, particularly in hospital settings.
The hospital use setting holds the largest share in the touch activated phlebotomy devices market, accounting for 44% of the total market. This growth is driven by the high volume of blood collection procedures performed in hospitals, where the need for efficient, safe, and rapid phlebotomy tools is critical. Hospitals require devices that can handle a wide range of patient demographics, including those in emergency care, critical care, and general medical procedures.
Touch-activated devices, particularly safety needles, are becoming the preferred choice due to their ability to minimize risk and improve the speed of procedures, which is crucial in high-pressure hospital environments. The adoption of touch-activated phlebotomy devices in hospitals is also supported by stringent health and safety regulations aimed at reducing healthcare-associated infections and injuries. Furthermore, as hospitals seek to improve operational efficiency and patient safety, the demand for advanced, easy-to-use blood collection tools is expected to rise. With healthcare facilities prioritizing both safety and efficiency, the hospital use setting is poised to remain the dominant sector in the touch activated phlebotomy devices market, driving its continued growth.
The global touch activated phlebotomy devices market is expanding as healthcare providers adopt safer and more efficient blood collection tools. These devices reduce needlestick risk and improve consistency in venous access, supporting quality and safety goals in clinical settings. Demand grows with rising diagnostic testing, outpatient care volume and focus on infection prevention. Use of touch activated technology enhances clinician control during draws, lowering complications and improving patient comfort. Growth spans hospitals, blood collection centres, labs and outpatient clinics where safer phlebotomy practice is increasingly prioritised.
What are the Key Drivers for the Global Touch Activated Phlebotomy Devices Market?
Patient and clinician safety is a primary driver that encourages adoption of touch activated phlebotomy devices. Hospitals and clinics focus on lowering needlestick injuries and reducing exposure to bloodborne pathogens, which supports investment in engineered safety solutions. Rising volume of diagnostic tests and preventive screenings increases frequency of blood draws, prompting facilities to adopt tools that improve procedure reliability. Regulatory standards and workplace safety protocols in many regions reinforce use of devices with integrated safety mechanisms. Advances in ergonomic design and user control enhance appeal among phlebotomists and nursing staff seeking consistent performance.
What are the Restraints for the Global Touch Activated Phlebotomy Devices Market?
One restraint is the higher cost of touch activated devices compared with traditional phlebotomy needles and systems. Budget constraints in some healthcare facilities, particularly smaller clinics or rural providers, may slow adoption. Some purchasers remain reluctant to switch from familiar tools unless clear cost benefit in safety or efficiency is demonstrated. Variation in reimbursement policies and budget cycles across regions influences purchase timing and scale. Training requirements for clinicians to adopt new devices and integrate them into workflow add time and resource needs. Supply chain challenges for safety devices in certain markets can also affect consistent availability.
What is the Key Trends in the Global Touch Activated Phlebotomy Devices Market?
A key trend is development of devices with improved tactile feedback and ease of use that support consistent vein access across diverse patient populations. Manufacturers are focusing on innovations that combine safety features with intuitive design to reduce learning curves for clinical staff. Integration with safety protocols and clinician training programs is becoming more common to ensure optimal use and reduce complications. Growing interest in sustainable device options and recyclable components influences product development. Data from real world use and safety reporting is being used to refine design and support purchasing decisions by health systems aiming to improve outcomes and operational efficiency.
The touch activated phlebotomy devices market is expected to grow across multiple regions, with varying compound annual growth rates (CAGRs) reflecting the adoption and demand in each country. Increasing healthcare awareness, the need for safer blood collection methods, and technological advancements in medical devices are driving the growth of this market. The devices offer improved safety features, ease of use, and efficiency, making them increasingly popular in healthcare settings. With rising demand for minimally invasive procedures and safer blood draw options, touch activated phlebotomy devices are gaining traction globally. By understanding country-specific growth trends, businesses can optimize their strategies to cater to the growing need for these advanced phlebotomy solutions.
| Country | CAGR (2026-2036) |
|---|---|
| China | 12.5% |
| United States | 10.5% |
| United Kingdom | 10.5% |
| Germany | 10.4% |
| Japan | 9% |
The touch activated phlebotomy devices market in China is projected to grow at the highest rate, with a CAGR of 12.5%. China’s growing healthcare needs, coupled with the increasing awareness of the importance of safe blood collection methods, are major drivers for this growth. The country’s expanding healthcare infrastructure and the rising demand for minimally invasive medical solutions contribute to the growing adoption of advanced phlebotomy devices. The Chinese government’s focus on improving healthcare services and technological advancements in medical devices further support the widespread adoption of touch activated phlebotomy devices. Additionally, China’s large population and the increasing incidence of medical procedures requiring blood collection create a significant market for these devices. As the healthcare system continues to modernize, the market for touch activated phlebotomy devices in China is expected to experience strong and sustained growth.
The touch activated phlebotomy devices market in the United States is expected to grow at a CAGR of 10.5%. The U.S. market benefits from a well-established healthcare infrastructure, high adoption of advanced medical technologies, and increasing focus on patient safety. The growing prevalence of chronic diseases, such as diabetes and cardiovascular conditions, which require frequent blood tests, is driving the demand for safer and more efficient blood collection methods. The widespread use of touch activated phlebotomy devices in hospitals, clinics, and laboratories supports the market’s growth. Additionally, the regulatory environment in the U.S. encourages the integration of advanced medical devices to enhance patient care and reduce the risks associated with traditional blood collection methods. As a result, the market for touch activated phlebotomy devices in the United States is expected to grow steadily, driven by these factors.
The touch activated phlebotomy devices market in the United Kingdom is projected to grow at a CAGR of 10.5%. The UK healthcare system, known for its high standards and focus on patient safety, is contributing to the adoption of advanced medical devices like touch activated phlebotomy solutions. As the need for safer blood collection methods increases, healthcare providers are increasingly adopting these devices to reduce the risk of needle-stick injuries and improve the efficiency of blood draws. The UK’s National Health Service (NHS) is a significant driver of medical device adoption, ensuring widespread access to these devices in public healthcare settings. Moreover, the growing demand for minimally invasive medical procedures supports the market growth. The UK is expected to continue experiencing steady growth in the adoption of touch activated phlebotomy devices in the coming years.
The touch activated phlebotomy devices market in Germany is expected to grow at a CAGR of 10.4%. Germany’s advanced healthcare system, along with its emphasis on medical innovation and patient safety, provides a strong foundation for the adoption of these devices. The increasing focus on reducing healthcare-associated risks, such as needle-stick injuries, is driving the demand for safer blood collection alternatives like touch activated phlebotomy devices. Germany’s large healthcare infrastructure, including hospitals and diagnostic centers, supports the widespread implementation of these devices. The regulatory environment in Germany also promotes the adoption of innovative medical technologies, ensuring that touch activated phlebotomy devices can be integrated into clinical practice effectively. As a result, Germany is expected to maintain steady growth in the adoption of touch activated phlebotomy devices.
The touch activated phlebotomy devices market in Japan is forecasted to grow at a CAGR of 9%. Japan’s aging population and the increasing demand for safer medical practices are key factors contributing to the growth of the market. The country’s healthcare system is renowned for its high standards, and there is a growing focus on reducing the risks associated with blood collection procedures. The adoption of touch activated phlebotomy devices is expected to increase as healthcare providers seek to enhance safety and minimize the risk of infections. Japan’s strong regulatory environment for medical devices ensures that these devices will continue to be integrated into healthcare practices, providing a steady market for their use. While the growth rate may be slower than in some other countries, Japan remains a key player in the global touch activated phlebotomy devices market due to its technological sophistication and patient care priorities.
The touch activated phlebotomy devices market is growing as healthcare providers seek safer and more efficient methods for blood collection. BD leads the market with its innovative touch-activated phlebotomy devices, which are designed to improve safety, reduce the risk of needlestick injuries, and enhance the efficiency of blood collection procedures. BD’s advanced technologies have positioned the company at the forefront of this market, offering devices that are widely adopted across healthcare settings. Greiner Bio-One, Terumo, and Nipro are key competitors, each offering a range of touch-activated devices that prioritize ease of use and safety. Greiner Bio-One provides specialized solutions with its Vacuette line, while Terumo and Nipro focus on creating high-quality, cost-effective devices suitable for various clinical applications.
B. Braun, Sarstedt, Cardinal Health, Medline, and Smiths Medical add to the competitive landscape by offering products that enhance the blood collection process. B. Braun and Sarstedt focus on developing reliable, touch-activated phlebotomy devices that cater to both hospital and laboratory needs. Cardinal Health and Medline provide a broad range of medical products, including blood collection devices, while Smiths Medical brings specialized innovations in blood collection technologies. These companies compete by offering advanced features such as improved ergonomics, reduced needlestick risks, and faster collection times, ensuring better outcomes for both healthcare providers and patients.
| Items | Values |
|---|---|
| Quantitative Units (2026) | USD Million |
| Device Type | Touch-Activated Safety Needles, Touch-Activated Blood Collection Sets, Touch-Activated Lancets, Other Devices |
| Use Setting | Hospitals, Diagnostics/Reference Labs, Clinics & Physician Offices, Other Settings |
| Safety Mechanism | Passive/Auto-Engage, User-Activated (touch) mechanisms, Hybrid/Other |
| Procurement | GPO/IDN Contracting, Distributor Procurement, Direct Tender/Other |
| Companies | BD, Greiner Bio-One, Terumo, Nipro, B. Braun, Sarstedt, Cardinal Health, Medline, Smiths Medical, Vacuette (Greiner) |
| Regions Covered | North America, Latin America, Western Europe, Eastern Europe, South Asia and Pacific, East Asia, Middle East & Africa |
| Countries Covered | United States, Canada, Mexico, Brazil, Argentina, Germany, France, United Kingdom, Italy, Spain, Netherlands, China, India, Japan, South Korea, ANZ, GCC Countries, South Africa |
| Additional Attributes | Dollar by sales by device type, use setting, safety mechanism, procurement model, and region. Includes market trends in touch-activated phlebotomy devices, focusing on safety needles, blood collection sets, and lancets. Highlights the role of passive/auto-engage, user-activated mechanisms, and hybrid safety features in improving phlebotomy safety. Focus on procurement models (GPO/IDN contracting, distributor procurement, direct tender) and the impact on market growth. |
The global touch activated phlebotomy devices market is estimated to be valued at USD 288.7 million in 2026.
The market size for the touch activated phlebotomy devices market is projected to reach USD 819.7 million by 2036.
The touch activated phlebotomy devices market is expected to grow at a 11.0% CAGR between 2026 and 2036.
The key product types in touch activated phlebotomy devices market are touch-activated safety needles, touch-activated blood collection sets, touch-activated lancets and other devices.
In terms of use setting, hospitals segment to command 44.0% share in the touch activated phlebotomy devices market in 2026.
Our Research Products
The "Full Research Suite" delivers actionable market intel, deep dives on markets or technologies, so clients act faster, cut risk, and unlock growth.
The Leaderboard benchmarks and ranks top vendors, classifying them as Established Leaders, Leading Challengers, or Disruptors & Challengers.
Locates where complements amplify value and substitutes erode it, forecasting net impact by horizon
We deliver granular, decision-grade intel: market sizing, 5-year forecasts, pricing, adoption, usage, revenue, and operational KPIs—plus competitor tracking, regulation, and value chains—across 60 countries broadly.
Spot the shifts before they hit your P&L. We track inflection points, adoption curves, pricing moves, and ecosystem plays to show where demand is heading, why it is changing, and what to do next across high-growth markets and disruptive tech
Real-time reads of user behavior. We track shifting priorities, perceptions of today’s and next-gen services, and provider experience, then pace how fast tech moves from trial to adoption, blending buyer, consumer, and channel inputs with social signals (#WhySwitch, #UX).
Partner with our analyst team to build a custom report designed around your business priorities. From analysing market trends to assessing competitors or crafting bespoke datasets, we tailor insights to your needs.
Supplier Intelligence
Discovery & Profiling
Capacity & Footprint
Performance & Risk
Compliance & Governance
Commercial Readiness
Who Supplies Whom
Scorecards & Shortlists
Playbooks & Docs
Category Intelligence
Definition & Scope
Demand & Use Cases
Cost Drivers
Market Structure
Supply Chain Map
Trade & Policy
Operating Norms
Deliverables
Buyer Intelligence
Account Basics
Spend & Scope
Procurement Model
Vendor Requirements
Terms & Policies
Entry Strategy
Pain Points & Triggers
Outputs
Pricing Analysis
Benchmarks
Trends
Should-Cost
Indexation
Landed Cost
Commercial Terms
Deliverables
Brand Analysis
Positioning & Value Prop
Share & Presence
Customer Evidence
Go-to-Market
Digital & Reputation
Compliance & Trust
KPIs & Gaps
Outputs
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
Activated Carbon Canisters Market Size and Share Forecast Outlook 2026 to 2036
Activated Persulfate Oxidation Systems Market Size and Share Forecast Outlook 2026 to 2036
Activated Carbon for Sugar Decolorization Market Forecast and Outlook 2025 to 2035
Activated Alumina Market Size and Share Forecast Outlook 2025 to 2035
Activated Carbon Fiber Market Size and Share Forecast Outlook 2025 to 2035
Touch Controller IC Market Size and Share Forecast Outlook 2025 to 2035
Activated Cake Emulsifier Market Size and Share Forecast Outlook 2025 to 2035
Activated Carbon Bags Market Size and Share Forecast Outlook 2025 to 2035
Touch Panel Market Size and Share Forecast Outlook 2025 to 2035
Touchless Sensing Market Size and Share Forecast Outlook 2025 to 2035
Touch Screen Film Market Size and Share Forecast Outlook 2025 to 2035
Activated Bleaching Earth Market Growth - Trends & Forecast 2025 to 2035
Activated Carbon Filter Market Growth - Trends & Forecast 2025 to 2035
Phlebotomy Equipment Market Analysis – Size, Share, and Forecast Outlook 2025 to 2035
Touchscreen Controller Market Growth - Trends & Outlook 2025 to 2035
Assessing Activated Carbon Market Share & Industry Trends
Market Share Breakdown of Activated Cake Emulsifier Suppliers
U.S. Phlebotomy Equipment Market Analysis – Trends, Growth & Forecast 2024-2034
Activated Partial Thromboplastin Test Market
Touchless Tubes Market
Touch Activated Phlebotomy Devices Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
